Skip to content

Comparison efficacy of wet-cupping and reform temperament for decrease blood pressure of patient with hypertension

Comparison efficacy of wet-cupping and reform temperament for decrease blood pressure of patient with hypertension

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138905114495N1
Enrollment
51
Registered
2011-06-22
Start date
2011-05-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Intervention group 1 : Drug therapy and plus wet-cupping. Drug therapy continued base on according to cardiologist for patient and researcher didn't have any intervention in drug thera
Treatment - Other
Treatment - Drugs
Intervention group 1 : Drug therapy and plus wet-cupping. Drug therapy continued base on according to cardiologist for patient and researcher didn't have any intervention in drug therapy and only reco
Intervention group 2 : Drug therapy and plus reform temperament. Drug therapy continued base on according to cardiologist for patient and researcher didn't have any intervention in drug therapy and on
Control group: Drug therapy. Drug therapy continued base on according to cardiologist for patient and researcher didn't have any intervention in drug therapy and only recorded their.

Sponsors

Vice chancellor for research of Islamic Azad University Tehran Medical Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included: Hypertension; age 30-60 years; not having a history of chronic disease such as diabetes and kidney; to do not have reform temperament or wet-cupping for 1 years ago. Exclusion criteria included: Experience unpleasant and serious accidents, such as relatives died in the past 6 months; females become pregnant during the study; current treatment with other complementary treatments.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood Pressure. Timepoint: Before intervention and every 2 weeks until 45 days after intervention. Method of measurement: Per mmHg with mercury sphygmomanometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Zarei

Islamic Azad University Tehran Medical Branch

m.zarei51@yahoo.com; m.zarei@iauq.ac.ir+98 58 1224 1029

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026